StockWatch
·
Biotechnology: Pharmaceutical Preparations
InvestmentJun 18, 2026, 08:31 AM

CDT Equity's Sarborg Stake Valued at $127.5M After Fundraise

AI Summary

CDT Equity Inc. noted Sarborg Limited's recent fundraise from a New York-based private investment fund, which implies a fully diluted valuation of approximately $638.3 million for Sarborg. Based on this, CDT's 1,020 shares in Sarborg are now valued at $127.5 million. The proceeds from the fundraise will support the launch of SarborgQ, Sarborg's new quantum computing division, and further development of its AI platform. CDT views this as validation of Sarborg's business model and expects to benefit from its continued growth.

Key Highlights

  • Sarborg Limited completed a fundraise at a consideration of $125,000 per share.
  • The fundraise implies a fully diluted valuation of approximately $638.3 million for Sarborg.
  • CDT Equity Inc. currently owns 1,020 shares in Sarborg.
  • CDT's shareholding in Sarborg is now valued at $127.5 million based on the new price.
  • Sarborg will use the proceeds to launch SarborgQ, a new quantum computing division.
  • Funds will also support expansion of proprietary datasets, IP generation, and AI platform development.